NASDAQ: PODD
Insulet Corp Earnings Dates, Reports, Calls

Insulet earnings were $428.8M for the trailing 12 months ending Sep 30, 2026, with 75.4% growth year over year. The latest PODD earnings report on Sep 30, 2026 announced Q3 2026 earnings of $141.1M, up 48.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PODD reported annual earnings of $247.1M, with -40.9% growth.

PODD past earnings growth

How has PODD's earnings growth performed historically?

Company
75.43%
Industry
-3.61%
Market
93.01%
PODD's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PODD's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
PODD's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

PODD earnings history

Current Revenue
$3.2B
Current Earnings
$428.8M
Current Profit Margin
13.4%

PODD Return on Equity

Current Company
29.5%
Current Industry
9.8%
Current Market
37.1%
PODD's Return on Equity (29.5%)... subscribe to Premium to read more.
High Return on Equity Performance

PODD Return on Assets

Current Company
13.4%
Current Industry
5.3%
PODD is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PODD announces earnings.

PODD Return on Capital Employed

Current Company
23.39%
Current Industry
10%
PODD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PODD vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PODD$713.80M$428.80M+122.62%$6.14
BIO$1.37B$1.02B-29.89%$37.88
GMED$953.90M$557.64M+17.23%$4.14
BRKR$155.50M-$167.30MN/A-$1.10
ALGN$924.56M$491.87M-5.99%$6.88

Insulet Earnings Reports & History FAQ

What were Insulet's earnings last quarter?

On PODD's earnings call on Nov 4, 2026, Insulet (NASDAQ: PODD) reported Q3 2026 earnings per share (EPS) of $2.03, up 63.71% year over year. Total PODD earnings for the quarter were $141.10 million. In the same quarter last year, Insulet's earnings per share (EPS) was $1.24.

If you're new to stock investing, here's how to buy Insulet stock.

Is Insulet profitable or losing money?

As of the last Insulet earnings report, Insulet is currently profitable. Insulet's net profit (also called net income) for the twelve months ending Sep 30, 2026 was $428.80 million, a 74.17% increase year over year.

What was PODD's earnings growth in the past year?

As of Insulet's earnings date in Nov 4, 2026, Insulet's earnings has grown 75.43% year over year. This is 79.04 percentage points higher than the US Medical Devices industry earnings growth rate of -3.61%. PODD earnings in the past year totalled $428.80 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.